Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurology | 4 | 2022 | 34 | 1.730 |
Why?
|
| Quality Improvement | 5 | 2022 | 425 | 1.300 |
Why?
|
| Polyneuropathies | 2 | 2022 | 10 | 1.280 |
Why?
|
| Nervous System Diseases | 2 | 2020 | 97 | 1.190 |
Why?
|
| Neurotology | 2 | 2018 | 5 | 0.780 |
Why?
|
| Deglutition Disorders | 1 | 2021 | 43 | 0.740 |
Why?
|
| Nerve Compression Syndromes | 1 | 2019 | 10 | 0.670 |
Why?
|
| Sciatic Nerve | 1 | 2019 | 22 | 0.670 |
Why?
|
| Iliac Vein | 1 | 2019 | 7 | 0.670 |
Why?
|
| Medication Reconciliation | 1 | 2019 | 11 | 0.650 |
Why?
|
| Brain Diseases | 2 | 2010 | 67 | 0.620 |
Why?
|
| Vestibular Diseases | 1 | 2018 | 9 | 0.620 |
Why?
|
| Ear Diseases | 1 | 2018 | 11 | 0.620 |
Why?
|
| Medication Errors | 1 | 2019 | 116 | 0.600 |
Why?
|
| Brain Ischemia | 1 | 2021 | 403 | 0.570 |
Why?
|
| Myasthenia Gravis | 1 | 2016 | 8 | 0.550 |
Why?
|
| Thiamine Deficiency | 1 | 2015 | 6 | 0.500 |
Why?
|
| Diet, Gluten-Free | 1 | 2015 | 7 | 0.500 |
Why?
|
| Sensory Receptor Cells | 1 | 2015 | 17 | 0.500 |
Why?
|
| Stroke | 2 | 2021 | 1138 | 0.480 |
Why?
|
| Registries | 1 | 2016 | 803 | 0.420 |
Why?
|
| Vertigo | 1 | 2012 | 17 | 0.410 |
Why?
|
| Diabetic Neuropathies | 1 | 2012 | 9 | 0.400 |
Why?
|
| Analgesics | 1 | 2012 | 100 | 0.370 |
Why?
|
| Practice Guidelines as Topic | 2 | 2012 | 703 | 0.360 |
Why?
|
| Popliteal Vein | 1 | 2010 | 3 | 0.350 |
Why?
|
| Eye Abnormalities | 1 | 2010 | 20 | 0.340 |
Why?
|
| Mononeuropathies | 1 | 2010 | 5 | 0.340 |
Why?
|
| Muscular Diseases | 1 | 2010 | 45 | 0.340 |
Why?
|
| Aneurysm | 1 | 2010 | 54 | 0.330 |
Why?
|
| Humans | 17 | 2022 | 59491 | 0.310 |
Why?
|
| Calcinosis | 1 | 2009 | 79 | 0.310 |
Why?
|
| Postoperative Complications | 1 | 2010 | 1134 | 0.210 |
Why?
|
| Electrodiagnosis | 2 | 2015 | 13 | 0.210 |
Why?
|
| Neural Conduction | 2 | 2015 | 28 | 0.210 |
Why?
|
| Hospitals, Community | 1 | 2021 | 71 | 0.180 |
Why?
|
| Arthritis, Juvenile | 1 | 2020 | 8 | 0.180 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2020 | 12 | 0.170 |
Why?
|
| Female | 7 | 2018 | 30906 | 0.160 |
Why?
|
| Vestibular Neuronitis | 1 | 2018 | 9 | 0.160 |
Why?
|
| Health Resources | 1 | 2019 | 88 | 0.150 |
Why?
|
| Middle Aged | 5 | 2019 | 16274 | 0.140 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 328 | 0.140 |
Why?
|
| Pyridostigmine Bromide | 1 | 2016 | 5 | 0.140 |
Why?
|
| Stroke Rehabilitation | 1 | 2017 | 45 | 0.140 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 388 | 0.140 |
Why?
|
| Neuromuscular Diseases | 1 | 2016 | 23 | 0.140 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2016 | 45 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2018 | 330 | 0.130 |
Why?
|
| Mass Screening | 1 | 2021 | 647 | 0.130 |
Why?
|
| Patient Safety | 1 | 2018 | 243 | 0.130 |
Why?
|
| Male | 4 | 2019 | 27559 | 0.120 |
Why?
|
| Quality of Life | 1 | 2020 | 1116 | 0.110 |
Why?
|
| Benign Paroxysmal Positional Vertigo | 1 | 2012 | 4 | 0.100 |
Why?
|
| Pregabalin | 1 | 2012 | 4 | 0.100 |
Why?
|
| Amitriptyline | 1 | 2012 | 8 | 0.100 |
Why?
|
| Physical Examination | 1 | 2012 | 103 | 0.100 |
Why?
|
| Clinical Coding | 1 | 2012 | 43 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2018 | 1914 | 0.100 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2012 | 79 | 0.090 |
Why?
|
| Dystroglycans | 1 | 2010 | 2 | 0.090 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2009 | 9 | 0.080 |
Why?
|
| Movement Disorders | 1 | 2009 | 23 | 0.080 |
Why?
|
| GTP Phosphohydrolases | 1 | 2009 | 59 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2018 | 5183 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 1 | 2009 | 250 | 0.070 |
Why?
|
| Adult | 3 | 2015 | 15782 | 0.070 |
Why?
|
| Bipolar Disorder | 1 | 2009 | 254 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 673 | 0.060 |
Why?
|
| Infant | 1 | 2010 | 1527 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 1462 | 0.050 |
Why?
|
| Mutation | 1 | 2009 | 2429 | 0.050 |
Why?
|
| Aged | 1 | 2016 | 13339 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 2039 | 0.050 |
Why?
|
| Betacoronavirus | 1 | 2020 | 160 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 220 | 0.040 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 187 | 0.040 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 199 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 608 | 0.030 |
Why?
|
| Spastin | 1 | 2009 | 3 | 0.020 |
Why?
|
| Anterior Horn Cells | 1 | 2009 | 6 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2009 | 29 | 0.020 |
Why?
|
| Motor Neuron Disease | 1 | 2009 | 29 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 173 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2009 | 80 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 195 | 0.020 |
Why?
|
| Genotype | 1 | 2009 | 642 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 900 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 1044 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 674 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2009 | 842 | 0.010 |
Why?
|